Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8671441 | Journal of Vascular Surgery | 2018 | 10 Pages |
Abstract
There are major limitations in the current state of evidence guiding treatment decisions in CLTI, particularly for severe anatomic patterns of disease treated via endovascular means. Periprocedural (30-day) mortality, amputation, and major adverse cardiac events are broadly similar across modalities. Patency rates are highest for saphenous vein bypass, whereas both patency and limb salvage are markedly inferior for prosthetic grafting to below the knee targets. Among endovascular interventions, percutaneous transluminal angioplasty and drug-eluting stents appear comparable for focal infrapopliteal disease, although no studies included long segment tibial lesions. Heterogeneity in patient risk, severity of limb threat, and anatomy treated renders direct comparison of outcomes from the current literature challenging. Future studies should incorporate both limb severity and anatomic staging to best guide clinical decision making in CLTI.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jehad MD, Jayanth MBBS, MPH, Noor MD, Sumaya MD, Mouaz MD, MSc, Larry J. MLS, Andrew BSc, MB, ChB Honours, MD, MBA, FRCSEd, Philippe MD, PhD, Michael S. MD, M. Hassan MD, MPH,